Burlingame, Ca. – January 26, 2016. AlerSense Incorporated is pleased to announce that Dr. Juan Carlos Ivancevich has joined the AlerSense Medical Advisory Board. AlerSense has created the world’s first smart airborne allergy and asthma early warning system alerting consumers as particles and toxins build.
Dr. Ivancevich is a world leader in allergy and immunology issues. Dr. Ivancevich served as the Secretary General and Vice President of the Latin American Society of Allergy, Asthma and Immunology and is currently the web editor-in-chief. Also Dr. Ivancevich served as President of the Argentinian Association of Allergy and Clinical Immunology, between 2007 and 2009. He was on the Board of Directors of the World Allergy Organization, and is currently the Editor in Chief of The World Allergy Organization website. Dr. Ivancevich served as an Adjunct member of the Board and Editor in Chief to the website of Interasma, part of the Global Asthma Association and currently Dr. Ivancevich is head of allergy and immunology at the Santa Isabel clinic in Buenos Aires. Additionally he is an Associate Professor of Immunology, Faculty of Medicine, Del Salvador University, in Buenos Aires.
“I see AlerSense as an important part of an overall allergy and asthma management plan. AlerSense will give patients vital information and precious time so they can both understand more about the airborne contaminants that may play a role in allergy and asthma as well as giving them the possibility to adjust their environment. I am recommending AlerSense to my patients”, says Dr. Ivancevich.
“We are extremely pleased to have Dr. Ivancevich as part of our team at AlerSense,” said Skip Sanzeri CEO of AlerSense. “We strive to produce the most efficacious product available, and we know that having global experts advising us is essential. We intend on continuing to build out a very strong Medical Advisory Board to complement our already talented group of PhD’s and scientists. Dr. Ivancevich is a world thought leader in asthma, allergy and immunology. We believe Dr. Ivancevich will help AlerSense produce a product that provides great value to people suffering from asthma, allergies, COPD and other respiratory issues”.
AlerSense™ units will be available in the spring of 2016. Interested customers may preorder AlerSense™ via the AlerSense™ website at www.AlerSense.com.
AlerSense™ stands for ‘Aler’ (Alert, Allergy), and ‘Sense’ (detect and report). AlerSense™ is committed to providing high quality consumer airborne contaminant sensing solutions. Based in Silicon Valley and Dublin, Ireland, AlerSense™ will help change the world by playing a role in reducing allergy and asthma issues.
For further information please visit www.AlerSense.com or send an email to info@AlerSense.com.
Tel 1 650 504 0465